PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-7.91%
Negative revenue growth while 3088.T stands at 9.91%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
0.58%
Gross profit growth under 50% of 3088.T's 7.11%. Michael Burry would be concerned about a severe competitive disadvantage.
0.43%
EBIT growth below 50% of 3088.T's 55.16%. Michael Burry would suspect deeper competitive or cost structure issues.
-2.15%
Negative operating income growth while 3088.T is at 43.75%. Joel Greenblatt would press for urgent turnaround measures.
-2.62%
Negative net income growth while 3088.T stands at 63.56%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-2.63%
Negative EPS growth while 3088.T is at 63.45%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-2.63%
Negative diluted EPS growth while 3088.T is at 63.56%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
16.03%
10Y revenue/share CAGR at 75-90% of 3088.T's 19.58%. Bill Ackman would press for new markets or product lines to narrow the gap.
-4.03%
Negative 5Y CAGR while 3088.T stands at 21.88%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-25.88%
Negative 3Y CAGR while 3088.T stands at 12.58%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
No Data
No Data available this quarter, please select a different quarter.
90.97%
Net income/share CAGR above 1.5x 3088.T's 60.62% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
0.73%
Positive 5Y CAGR while 3088.T is negative. John Neff might view this as a strong mid-term relative advantage.
-24.36%
Negative 3Y CAGR while 3088.T is 15.19%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
63.24%
Equity/share CAGR of 63.24% while 3088.T is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
No Data
No Data available this quarter, please select a different quarter.
-10.18%
Negative 3Y equity/share growth while 3088.T is at 37.59%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
52.78%
Below 50% of 3088.T's 200.00%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
5.88%
AR growth of 5.88% while 3088.T is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
7.68%
Inventory growth well above 3088.T's 1.60%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-0.22%
Negative asset growth while 3088.T invests at 2.32%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
4.68%
BV/share growth above 1.5x 3088.T's 1.17%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-9.08%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
1.39%
SG&A declining or stable vs. 3088.T's 3.01%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.